Current Gastroenterology Reports

, Volume 6, Issue 1, pp 37–43

Hepatocellular carcinoma: Updates in primary prevention

Authors

  • Will J. FechtJr
    • Division of Gastroenterology and HepatologySaint Louis University School of Medicine
  • Alex S. Befeler
    • Division of Gastroenterology and HepatologySaint Louis University School of Medicine
Article

DOI: 10.1007/s11894-004-0024-3

Cite this article as:
Fecht, W.J. & Befeler, A.S. Curr Gastroenterol Rep (2004) 6: 37. doi:10.1007/s11894-004-0024-3

Abstract

Hepatocellular carcinoma is a significant cause of mortality worldwide and a growing problem in the United States. Treatment options are often limited, and median survival is less than 1 year. Thus, prevention may provide the best opportunity to alter the natural history of this disease. Primary prevention is best exemplified by the successes of such public health measures as universal hepatitis B vaccination. Such antiviral therapies as interferon may also have a role. Lessons can be learned from complementary and alternative medicine. Nevertheless, more work is needed in understanding hepatocarcinogenesis and in developing models to assess potential chemopreventive agents.

Download to read the full article text

Copyright information

© Current Science Inc 2004